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Abstract: The lectin found in the tubers of the Winter Aconite (Eranthis hyemalis) plant (EHL) is
a Type II Ribosome Inactivating Protein (RIP). Type II RIPs have shown anti-cancer properties and
have great potential as therapeutic agents. Similarly, colloidal gold nanoparticles are successfully
used in biomedical applications as they can be functionalised with ligands with high affinity and
specificity for target cells to create therapeutic and imaging agents. Here we present the synthesis and
characterization of gold nanoparticles conjugated with EHL and the results of a set of initial assays
to establish whether the biological effect of EHL is altered by the conjugation. Gold nanoparticles
functionalised with EHL (AuNPs@EHL) were successfully synthesised by bioconjugation with
citrate gold nanoparticles (AuNPs@Citrate). The conjugates were analysed by UV-Vis spectroscopy,
Dynamic Light Scattering (DLS), Zeta Potential analysis, and Transmission Electron Microscopy
(TEM). Results indicate that an optimal functionalisation was achieved with the addition of 100 µL
of EHL (concentration 1090 ± 40 µg/mL) over 5 mL of AuNPs (concentration [Au0] = 0.8 mM).
Biological assays on the effect of AuNPs@EHL were undertaken on Caenorhabditis elegans, a free-living
nematode commonly used for toxicological studies, that has previously been shown to be strongly
affected by EHL. Citrate gold nanoparticles did not have any obvious effect on the nematodes.
For first larval stage (L1) nematodes, AuNPs@EHL showed a lower biological effect than EHL. For L4
stage, pre-adult nematodes, both EHL alone and AuNPs@EHL delayed the onset of reproduction
and reduced fecundity. These assays indicate that EHL can be conjugated to gold nanoparticles and
retain elements of biocidal activity.
Keywords: Caenorhabditis elegans; toxicity; gold nanoparticles; nanocomposites; lectin protein;
Reactive Oxygen Species (ROS)
1. Introduction
Lectins are a class of proteins ubiquitously expressed in plants, animals, bacteria, and viruses.
They are well known for their ability to agglutinate erythrocytes, and their ability to bind carbohydrates
selectively based on the individual sugar specificity of the lectin [1,2]. Plant lectins play a key
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role in plants’ defences [3,4]; insecticidal, antifungal, and antiviral qualities have also been widely
described [5–8]. Eranthis hyemalis (Winter Aconite) is a late winter/early spring flowering perennial
plant of the family Ranunculaceae. E. hyemalis possesses a proteinaceous toxin (named Eranthis hyemalis
lectin, EHL), found to cause agglutination of erythrocytes as well as impacting on the fitness of
some agricultural pests and plant viruses [5,9]. To date, E. hyemalis is the sole representative of
the Ranunculaceae to be reported to express lectin activity. Due to the structural and toxicity
studies conducted [5,9–11], EHL should be classed as a Type II Ribosome Inactivating Protein (RIP).
RIPs are a class of enzymes (EC 3.2.2.22) with a mode of action which results in the breakage of
a glycosidic bond in the 28s rRNA in the 60S subunit of the ribosome, resulting in the disruption of
protein synthesis and subsequent cell death. EHL shows specificity for N-acetyl-galactosamine [5,9],
an overexpressed and incompletely glycosylated sugar in the Tn antigen which characterizes cancer
linked O-glycans [12]. Other N-acetyl-galactosamine specific RIPs such as the Mistletoe lectin and
Riproximin have demonstrated promising therapeutic relevance as anticancer agents [13–15]. EHL
could therefore have a promising future as an anticancer agent, if its toxicity can be harnessed and
tuned to appropriate levels.
Previous work by some of the authors has shown biocidal effects of EHL against the free-living
nematode Caenorhabditis elegans [16]. C. elegans is a well-established model organism for initial
toxicological studies due to the conserved nature of its biological and biochemical processes, including
the stress response and disease pathways [17]. A wide range of available mutants, a short life cycle,
a well-documented life history, and a largely transparent body (which makes it possible to observe
unusual effects easily), are some of the advantages of C. elegans [18]. Developing C. elegans individuals
pass through a well-defined set of life stages, with individuals hatching as first larval stage (L1)
worms. These L1 worms subsequently molt through three further larval stages—the L2, L3, and L4
stages—before maturing as adults. Development is temperature dependent and takes approximately
3 days at 20 ◦C. Newly hatched L1 worms measure around 0.25 mm in length, and in their adult stage
they reach up to 1 mm. An interesting characteristic of C. elegans is its ability to enter an alternate L3 life
cycle stage known as the dauer larvae. Naturally induced dauer larval arrest occurs when L1 and L2
larva are exposed to environments not suited for growth and reproduction [19]. These environments
are characterised by a depleted food source and population overcrowding, with the chemosensory
cues and signals for these detected by the L1 larvae. As part of development into dauer larvae, worms
develop a specialized outer cuticle, and seal their mouths, preventing feeding. In combination with
changes in their metabolism, these adaptations mean that dauer larvae have an increased lifespan,
an enhanced resistance to environmental stress and are resistant to many chemical treatments that
would kill other lifecycle stages. This resulting dauer larvae is in an arrested developmental state
(a temporary halt in its development), and can survive for months until conditions improve, at which
point development resumes with dauer larvae moulting in to L4s [19].
Colloidal gold nanoparticles (AuNPs) have long been exploited in science for their optical
properties. The applications of AuNPs have increased enormously in recent years and are used
routinely in both material science and within biomedical sciences as bioimaging agents, therapeutic
agents, and drug delivery vehicles [20–23]. AuNPs can be functionalized with both therapeutic and
imaging agents simultaneously, thus are a powerful tool in cellular studies [24]. Gold nanoparticles can
be functionalized with ligands with high affinity and specificity for target cells such as the Tn antigen,
which is where conjugating gold nanoparticles with a RIP such as EHL presents an opportunity to fine
tune EHL’s biological effects.
Herein we present the synthesis and characterization of AuNPs conjugated with EHL
(AuNPs@EHL), and the preliminary study of the effects of AuNPs@EHL on C. elegans. The aim
was to establish the viability of the conjugate and to perform a set of initial assays to establish if
the biological effect of EHL is altered by the conjugation. The conjugates were analysed by UV-Vis
spectroscopy, Dynamic Light Scattering (DLS), Zeta Potential analysis, and Transmission Electron
Microscopy (TEM). Biological assays on the effect of AuNPs@EHL on C. elegans were performed
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using first life stage (L1) and pre-adult stage (L4) nematodes, and the results compared to previously
published data on the effect of EHL on L1 nematodes [16]. Additionally, the effects of naked AuNPs
on L1 and L4 nematodes, and the effect of EHL on L4s were also studied.
2. Materials and Methods
2.1. Materials
Tetrachloroauric (III) acid (HAuCl4·3H2O), Sodium hydroxide (NaOH), Hydrochloric acid (HCl),
Sodium chloride (NaCl), and Sodium citrate tribasic (C6H5Na3O7·2H2O) were purchased from Sigma
Aldrich (St. Louis, MO, USA), Strem Chemicals (Newton, UK), Fluka (St. Louis, MO, USA) or Panreac
(Barcelona, Spain), and used without further purifications. Acetonitrile (CAN, 99.9% purity) and
acetic acid glacial (99.7% purity) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Ethanol
(EtOH, 96% purity) was purchased in Panreac (Barcelona, Spain). Water was always Milli-Q grade
by Millipore.
Protein quantification was accomplished by measuring the absorbance at 595 nm with the use of
a Bradford Protein Assay using a CLARIOStar® High performance monochromator multimode BMG
Labtech, Germany from the Proteomass-BIOSCOPE Facility lab. The transmission electron microscopy
(TEM) images were obtained using a JEOL JEM 1010F transmission electron microscope from the
CACTI, University of Vigo, (Spain), operating at 100 kV. Samples were prepared dropping 5 µL of
the colloidal suspension on a copper grid coated with a continuous carbon film, and the solvent was
allowed to evaporate. TEM Images were characterized using ImageJ software (Image 1.51 h, Wayne
Rasband, National Institutes of Health, Bethesda, MD, USA) [25], with a minimum of three hundred
nanoparticles measured. The size measurements were performed with the nanoparticles diluted in
1 mL of water in a Zetasizer Nano ZS instrument (Malvern Instruments, Malvern, Panalytical, UK) in
the PROTEOMASS facilities. Zeta potential quantification was carried out in the same Zetasizer Nano
ZS instrument.
2.2. Synthesis of EHL Conjugated Gold Nanoparticles (AuNPs@EHL)
The AuNPs@Citrate were prepared by modification of a previously published protocol [26].
An aqueous solution (125 mL) containing 49 mg of tetrachloroauric (III) acid (HAuCl4·3H2O) was
heated until boiling point without reflux to ensure a low temperature gradient in the walls of the flask;
the solution was kept boiling for 10 min. Then, a pre-boiled aqueous solution (12.5 mL) containing
147 mg of sodium citrate tribasic (C6H5Na3O7·2H2O) was added rapidly. The reaction mixture was
heated to boiling for an additional 15 min, and then allowed to cool to ~25 ◦C and left with magnetic
stirring overnight. The reaction was then diluted to a final volume of 140 mL with milliQ water
and was transferred into a glass bottle for storage. The final obtained citrate gold nanoparticles
(AuNPs@Citrate) presented a concentration of 0.8 mM in terms of Au (0) (See SI for details, Figure S1)
and were used without purification.
To achieve the bioconjugation of the AuNPs@Citrate with EHL, the protein was suspended in
Phosphate Buffer Saline (PBS) solution. Quantification via Bradford technique indicated an EHL
concentration of 1090 ± 40 µg/mL. Six experiments were performed in order to characterize the
optimal quantity of EHL to achieve the stabilization of the nanoparticles: 25 µL, 50 µL, 100 µL, 200 µL,
300 µL, and 500 µL of EHL solution were used. On each case, the EHL solution was added onto
5 mL of AuNPs@Citrate ([Au (0)] = 0.8 mM) and left under vigorous stirring at room temperature
for 2 h, to ensure effective functionalization. The nanoparticles obtained—AuNPs@EHL-1 (25 µL),
AuNPs@EHL-2 (50 µL), AuNPs@EHL-3 (100 µL), AuNPs@EHL-4 (200 µL), AuNPs@EHL-5 (300 µL),
AuNPs@EHL-6 (500 µL)—were isolated by centrifugation at 14,000 rpm during 25 min, and then
suspended in PBS solution. A second centrifugation cycle and resuspension in 5 mL of MilliQ water
were performed. The first supernatant was filtered in a cellulose filter of 0.22 µm, and quantified
by the Bradford technique, in order to determine EHL concentration at the nanoparticles surface.
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AuNPs@EHL-3 (100 µL) was selected to perform the biological studies (See Figures S2 and S3 in the
Supplementary Information, SI).
2.3. Nematode Assay
Worms were obtained from the Caenorhabditis Genetics Center and maintained using standard
methods [27] on nematode growth media plates (NGM) using an Escherichia coli OP50 strain food
source. C. elegans strain N2 was used for the assays. In all experiments, treatments and genotypes were
blind coded, the position of plates within experimental blocks was randomised, and any contaminated
plates displaying evidence of fungal growth were excluded from all analysis. Assays were initiated
using arrested and synchronised C. elegans first stage larvae (L1s) obtained by allowing eggs, isolated
from gravid hermaphrodites by hypochlorite treatment [27], to hatch on NGM plates in the absence of
food for 24 h at 20 ◦C.
For the experiments on L1 stage worms, synchronised L1s were incubated in 15 mL eppendorf
tubes at 20 ◦C in a solution of one of four treatments (see below) for 6 h. Three replicates of each
treatment were made. After incubation, all treatments were subjected to a cycle of three washes with
M9 buffer [27] with a 2 min centrifugal spin at 2000 g. Worms were then added to seeded (Escherichia coli
OP50) NGM plates and incubated at 20 ◦C. Plates were then scored on day 3 for survival, arrested
development, and for dauer larvae formation.
For the experiments on L4 stage worms, synchronised L1s were placed on seeded NGM plates
and incubated at 20 ◦C until the L4 stage was reached. Treatment was then carried out in the same
set of liquid conditions as experiment 1 for 18 h, with tubes placed in a shaking incubator at 20 ◦C
overnight. As previously, worms were then washed three times and moved onto en masse onto NGM
plates (one plate per tube). L4 stage worms were then individually picked from these plates onto
seeded NGM plates, 50 per treatment. Worms were then transferred to new plates daily during the
reproductive period, with progeny allowed to develop for 2 days before they were counted. Treatments
were as follows: First, M9 liquid nutrient media and EHL @ [1.51 mg/mL]; second, M9 liquid nutrient
media and AuNPs@EHL-3; third, M9 liquid nutrient media and AuNPs@EHL; and fourth, M9 liquid
nutrient media.
3. Results and Discussion
3.1. Synthesis and Characterization of the Bioconjugated Gold Nanoparticles (AuNPs@EHL)
AuNPs@EHL were synthesized by attaching the protein to the nanoparticles surface through
adsorption. This methodology has been widely adopted to prepare many nanoparticles/protein
bioconjugates [28–31]. In our case, the bioconjugation was achieved by incubating the AuNPs@Citrate
in water solution, with an EHL solution in phosphate-buffered saline (PBS). The particles were
analyzed by UV-Vis spectroscopy (JASCO Co., Tokyo, Japan), DLS (MALVERN, Panalytical, UK),
Zeta Potential (MALVERN, Panalytical, UK), and TEM (JEM 1010, JEOL, Tokyo, Japan) analysis.
The ruby red colloidal solution of AuNPs@Citrate presents a Localized Surface Plasmon Resonance
(LSPR) band at 519 nm in the UV-Vis spectrum (Figure S1). TEM analysis shows that the spherical
AuNPs@Citrate have an average size 14.4 nm (SD = 1.3) (see Figure 1). DLS experiments indicated that
the AuNPs@Citrate measured 18.80 nm in Z-average, with a Zeta Potential equal to −43.6 mV/cm,
confirming the nanoparticles stabilization by citrate molecules. The concentration of the gold colloid
obtained, in terms of Au (0), was calculated from the absorption at 400 nm [32–34]. Thus, we obtained
a concentration of [Au (0)] = 0.8 mM (see SI for details).
An incubation process was performed to conjugate the AuNPs@Citrate with EHL; the concentration
of the EHL solution used (determined by the Bradford technique) was 1090 ± 40 µg/mL.
Six experiments were performed in order to characterize the optimal quantity of EHL to achieve
the stabilization of the nanoparticles. The following volumes of EHL solution were used: 25 µL
(AuNPs@EHL-1), 50 µL (AuNPs@EHL-2), 100 µL (AuNPs@EHL-3), 200 µL (AuNPs@EHL-4), 300 µL
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(AuNPs@EHL-5), and 500 µL (AuNPs@EHL-6). All the nanoparticles obtained were characterized by
UV-Vis spectroscopy, DLS, Zeta Potential, and TEM. Results are summarized in Table 1 and Figure S3
(see SI).Materials 2018, 11, 1363 5 of 12 
 
 
Figure 1. UV-Vis spectrum (a) histogram (b) and low magnification TEM images (c,d) of 
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Table 1. AuNPs@EHL solution composition for each experiment, DLS, and Zeta Potential Values and 
protein amount on the nanoparticles ([EHL] = concentration of EHL). 
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Zeta Potential (mV/cm) −23.1 −19.8 −27.8 −24.6 −20.2 −29.4 
EHL, Eranthis hyemalis lectin. 
Addition of low quantities of EHL (AuNPs@EHL-1 and AuNPs@EHL-2) does not allow the 
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functionalization. As it can be seen in Figure 2, a red shift on the LSPR band was observed. In 
addition, the aggregation of the nanoparticles was confirmed by the increase in Z-average value 
obtained for this samples (see Figures 3 and S2 in SI). TEM images also confirm that aggregation has 
occurred (see Figure 4a). Due to its dimeric structure, EHL could act as a link between the 
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Figure 1. UV-Vis spectrum (a) histogram (b) and low magnification TEM images (c,d) of
AuNPs@Citrate. The histogram is derived from measurements of 300 nanoparticles made in
ImageJ software.
Table 1. AuNPs@EHL solution composition for each experiment, DLS, and Zeta Potential Values and
protein amount on the nanoparticles ([EHL] = concentration of EHL).
AuNPs@EHL Sample 1 2 3 4 5 6
Vol. EHL added (µL) 25 50 100 200 30 50
Total vol. of the reaction (µL) 5025 5050 5100 5200 5300 5500
Mass EHL in the reaction (µg) 27.3 54.5 109 218 327 545
Mass EHL in supernatant (µg/mL) 3.1 ± 0.1 7.4 ± 0.3 4.0 ± 0.1 40 ± 2 61.1 ± 0.4 84 ± 3
ass L in VT supernatant (µg) 15.6 ± 0.5 37.4 ± 0.3 20.4 ± 0.1 208.0 ± 10 323.8 ± 2 462.0 ± 17
[EHL] in the NPs (µg) 11.7 17.1 88.6 10.0 3.2 .
Z-Average value (nm) 266.4 90.3 54.4 51.7 60.8 51.3
Polydispersity Index (PDI) 0.29 0.26 0.28 0.42 0.44 0.44
Zeta Potential (mV/cm) −23.1 −19.8 −27.8 −24.6 −20.2 −29.4
EHL, Eranthis hyemalis lectin.
Addition of low quantities of EHL (AuNPs@EHL-1 and AuNPs@EHL-2) does not allow the
stabilization of the colloidal system, and induces nanoparticles aggregation by partial functionalization.
As it can be seen in Figure 2, a red shift on the LSPR band was observed. In addition, the aggregation
of the nanoparticles was confirmed by the increase in Z-average value obtained for this samples
(see Figures 3 and S2 in SI). TEM images also confirm that aggregation has occurred (see Figure 4a).
Due to its dimeric structure, EHL could act as a link between the nanoparticles, and thus induce
aggregation in the colloidal system. Moreover, due to the incomplete formation of the nanoparticles’
corona, in the presence of PBS salts it could modify the isotropy charge produced by the citrate
adsorbed in the surface, resulting in the formation of nano-aggregates.
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Moreover, a significant increase in PDI (polydispersity index) was observed for AuNPs@EHL-4, 
AuNPs@EHL-5 and AuNPs@EHL-6 (see Figures 3 and S2 in SI). These results suggest that the 
colloidal systems conjugated in these conditions were composed of AuNPs@EHL and an excess of 
EHL molecules. In our case, additional centrifugation cycles were not able to wash the unreacted 
EHL. To this respect, the decrease in the rotational speed in the time intervals studied (between 20 
min and 1 h) resulted in a considerable increase in the concentration of AuNPs in the supernatant. 
(See Figure S3 in SI). 
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added. 
In an attempt to quantify the amount of protein on the surface of NPs, we have analyzed the first 
supernatant obtained during the purification process of the nanoparticles using the Bradford 
technique. For higher amounts of EHL (AuNPs@EHL-4, AuNPs@EHL-5, and AuNPs@EHL-6), this 
supernatant was not completely clear and still contained nanoparticles, even after filtering, which 
can produce an erroneous reading using the Bradford technique. This is because in spectroscopic 
quantification the wavelength used may overlap with the LSPR band of the AuNPs, resulting in the 
appearance of increased protein values (see Table 1). 
Figure 2. UV-Vis spectra of the different AuNPs@EHL samples synthesized: (a) AuNPs@EHL-1,
AuNPs@EHL-2, and AuNPs@EHL-3; and (b) AuNPs@EHL-4, AuNPs@EHL-5, and AuNPs@EHL-6.
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and (b) PDI (polydispersity Index) of the AuNPs@EHL obtained s a function of EHL amounts added.
For higher amounts of EHL (AuNPs@EHL-4, AuNPs@EHL-5, and AuNPs@EHL-6), saturation of
the nanoparticles surface occurs, as shown by the similar max of the LSRP band when compared with
AuNPs@EHL-3, together with the similar Z average obtained (see Figures 3 and S2 in SI). Moreover,
a significant increase in PDI (polydispersity index) was observed for AuNPs@EHL-4, AuNPs@EHL-5
and AuNPs@EHL-6 (see Figures 3 and S2 in SI). These results suggest that the colloidal systems
conjugated in these conditions were composed of AuNPs@EHL and an excess of EHL molecules.
In our case, additional centrifugation cycles were not able to wash the unreacted EHL. To this respect,
the decrease in the rotational speed in the time intervals studied (between 20 min and 1 h) resulted in
a considerable increase in the concentration of AuNPs in the supernatant. (See Figure S3 in SI).
In an attempt to quantify the amount of protein on the surface of NPs, we have analyzed the first
supernatant obtained during the purification process of the nanoparticles using the Bradford technique.
For higher amounts of EHL (AuNPs@EHL-4, AuNPs@EHL-5, and AuNPs@EHL-6), this supernatant
was not completely clear and still contained nanoparticles, even after filtering, which can produce
an erroneous reading using the Bradford technique. This is because in spectroscopic quantification
the wavelength used may overlap with the LSPR band of the AuNPs, resulting in the appearance of
increased protein values (see Table 1).
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The results obtained suggest that the best functionalization is achieved with the addition of 100 µL
of protein (1090 ± 40 µg/mL) onto 5 mL of AuNPs@Citrate solution. The AuNPs@EHL obtained
(sample AuNPs@EHL-3) show a high percentage of protein functionalized (17.7 g/mL); TEM images
and DLS analysis confirm lack of aggregation and the stability of the resulting colloidal solution
(See Figures 4b and S2 in SI). UV-Vis spectra show a redshift in the LSPR band from 519 nm to 528 nm
(see Figure 3) suggests a composition change on the surface of the nanoparticles, indicative of the
protein adsorption [35]. The Z-average increased from 18.8 nm (for AuNPs@Citrate) to 54.4 nm for
AuNPs@EHL-3.
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Figure 4. TEM images of AuNPs@EHL when different amounts of protein are added: (a) AuNPs@EHL-2
(25 µL), (b) AuNPs@EHL-3 (100 µL), (c) AuNPs@EHL-5 (200 µL), and (d) AuNPs@EHL-2 (500 µL).
In all cases, the nanoparticles go through two centrifugation cycles (14,000 rpm × 25 min) and are
resuspended in MilliQ water.
In order to show that the EHL is indeed conjugated to the surface of the nanoparticles, a test
was carried out by adding 200 L of 2 M NaCl to a solution of 3 mL of the respective gold colloid
(factor dilution 1:10); results are shown in Figure 5. When NaCl was added to the AuNPs@Citrate,
the colloid aggregation occurred. This phenomenon can be visualized through the color change of the
solution from red to blue accompanied by a marked red-shift in λmax of the LSRP band. Due to the
presence of electrolytes such as sodium chloride, the negative charge of the colloids is masked causing
an imbalance between the repulsive and attractive forces and producing colloid aggregation [36].
The addition of NaCl onto AuNPs@EHL-3 did not result in any destabilization of the system, showing
that EHL molecules are on the nanoparticles surface. Analysis by DLS of the sample AuNPs@EHL-3 in
100% PBS again confirms the presence of the EHL protein on the surface of the AuNPs (see Figure S3).
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3.2. Biological Activity against C. elegans
C. elegans is a well-established model in toxicological research to investigate toxicological
responses at a whole organism level [37–39]. The nematode has also been used specifically in relation
to the toxicology of nanoparticles [40,41]. The effect of AuNPs@EHL on C. elegans was investigated
and compared to the effect of AuNPs@Citrate treatment and EHL treatment. The biological studies
were performed using AuNPs@EHL-3 (which from now on will be referred to as AuNPs@EHL).
Previous work by some of the authors has shown that EHL has biocidal properties against C. elegans,
producing a significant reduction in fecundity, development and growth. Additionally, the authors
reported a high incidence of abnormal dauer development when arrested L1 larvae were treated
with EHL and then maintained on food, i.e., EHL treatment resulted in dauer larvae formation under
conditions that produced 100% non-dauer development in non-treated worms. These EHL-induced
dauer larvae were also unable to resume development when maintained on food. The authors called
this a “lectin-induced effect” and suggested that the occurrence of dauer formation and a failure to
recover in the presence of food indicates that EHL is binding specifically to amphid neurons [16].
Here, two sets of experiments were performed. The first set was a replication of the work on
the effects of EHL on C. elegans [16], using AuNPs@EHL. The second set of experiments (set 2) were
carried out using L4 stage (pre-adult) worms and had not previously been conducted with EHL.
An observation that the AuNPs@EHL sample did not agglutinate erythrocytes, a characteristic of the
native protein, was recorded prior to commencement of the experiments. This effect suggests that
conjugation changes important properties in the native protein.
For the first set of experiments L1 stage worms were treated with AuNPs@Citrate, AuNPs@EHL,
and EHL, as well as a control group with no treatment. For the treated L1s, the expected dauer
larvae and developmental arrest in response to EHL treatment was observed. However, there is
no dauer larvae formation in response to AuNPs@Citrate or AuNPs@EHL, and none in the control.
As previously reported, EHL also killed L1s in this assay, whilst the other treatments did not differ
in L1 survival (see Table 2). From these results, we conclude that AuNPs@Citrate do not obviously
affect L1s, and that the AuNPs@EHL do not replicate the EHL effect. In conjunction with the empirical
observation that agglutination properties were absent from the AuNPs@EHL sample, this would
indicate that a conformational change has occurred potentially in the protein induced by conjugation
to the nanoparticles, which blocks the EHL neuronal binding effects.
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Table 2. EHL treatment affects survival and development of treated C. elegans L1s. When scored,
adult worms were only observed on 3 of the 12 EHL plates, with worms showing varied degrees of
developmental delay.
Treatment No. of Plates L1s per Plate Mean % Survival(min. and max.)
Mean % Dauer Formation
(min. and max.)
Control 11 54.6 ± 3.8 68 (53–81) 0
EHL 12 64.2 ± 7.0 23 (11–40) * 24 (0–45) *
AuNPs@Citrate 11 58.6 ± 3.2 73 (54–84) 0
AuNPs@EHL 12 48.7 ± 6.6 68 (49–83) 0
* Denotes treatments where the proportion of surviving worms or dauer larvae differs from that observed in the
Control (p < 0.05, by Mann-Whitney for the analysis of % survival and by Fisher’s Exact Test with for the analysis of
% dauer larvae formation, both with Bonferroni adjustment to correct for multiple testing).
In the second set of experiments, using L4 stage worms, there was a small effect on lifetime
fecundity in the EHL treated worms, and a delay in reproduction in both the EHL treated and the
AuNPs@EHL worms; whilst naked nanoparticles did not obviously affect the L4 stage worms. We can
thus conclude and that AuNPs@EHL does have a biological activity. For the treated L4s, there was
a difference between treatments in lifetime fecundity (TREATMENT: F3,68 = 2.76, p = 0.049) that is
a consequence of a small reduction in lifetime fecundity in the EHL treated worms (EHL treatment
significantly different to the control and nanoparticle-treated worms by Fisher’s post-hoc testing)
(Figure 6, panel A). There is also variation between treatments in early reproduction (H = 14.22, df = 3,
p = 0.003), with both the EHL treated and the EHL conjugated nanoparticle treated worms showing
a reduced early fecundity (p < 0.05 in comparison to control worms via Mann-Whitney test) (Figure 6,
panel B).
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Figure 6. EHL conjugated nanoparticles (AuNPs@EHL) affect early reproduction (b), but not total
reproduction (a) of C. elegans L4 stage.
The L4 assays conducted show that AuNPs@EHL do still retain some activity, suggesting that
ingestion in the absence of glyconjugate binding (which is absent in the L1 assay) of the molecule may
present a low level of toxicity. The observation that AuNPs@EHL do not agglutinate erythrocytes
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would suggest that this is a factor. Of course, the inverse hypothesis may also be worthy of
investigation, that the toxic A-chain activity may have been altered and that binding still occurs
without the cytotoxic effects seen in the intact molecule. As non-RIP lectins have been shown to bind
to epithelial cells in the gut causing reduced fitness [42], this requires further study to establish the
exact reason for the reduction in toxicity.
4. Conclusions
The synthesis and characterization of gold nanoparticles conjugated with EHL (AuNPs@EHL)
was successfully carried out; optimal functionalization was achieved with the addition of 100 µL
of EHL (concentration 1090 ± 40 µg/mL) on 5 mL of AuNPs@Citrate ([Au0] = 0.8 mM). Biological
assays on the effect of AuNPs@EHL on C. elegans were performed, using first life stage (L1) and
pre-adult stage (L4) nematodes, and compared to the effect of naked gold nanoparticles and EHL
alone. This work shows that the activity of EHL is altered by conjugation and as such resulted in
a lessened biological effect towards L1 stage worms. For the assays performed with L4 nematodes,
naked nanoparticles do not produce any obvious effect on the worms, while AuNPs@EHL conjugated
nanoparticles do produce a similar biological activity to that produced by EHL alone. This indicates
that the biological effects of EHL can be separated. Extension of this work to cell lines would therefore
be of interest, particularly to determine the mechanism by which the non-toxic effects on L4 worms
are produced.
Supplementary Materials: The following are available online at http://www.mdpi.com/1996-1944/11/8/1363/
s1, Figure S1: Spectroscopic profile of AuNPs@Citrate (Dilution Factor = 1:10), Figure S2: Size distribution
measured by Dynamic Light Scattering. Distribution by % Intensity and % Volume, Figure S3: Size distribution
measured by Dynamic Light Scattering of AuNPs@EHL-3 in water and PBS. Distribution by %Intensity and
%Volume.
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